Owkin develops AI to automate biopharmaceutical research and support clinical research using multimodal patient data.

Products & media

K Pro

An AI research assistant that combines patient data and specialized biological tools to support drug discovery and clinical-development decisions.

Pathology Explorer

An AI pathology agent for detecting, segmenting, and classifying cells in cancer tissue images, with publicly released model weights and implementation.

MOSAIC

A spatial multiomics cancer dataset initiative led by Owkin and research partners, with licensed patient-data access for pharmaceutical research.

OKN4395

An investigational EP2, EP4, and DP1 inhibitor in Phase 1 development for advanced solid tumors through Owkin affiliate Epkin.

OKN3201

An investigational bispecific antibody-drug conjugate being developed to improve targeting of solid tumors.

Team

1 person across company lists

Founders

1 person

List
Thomas Clozel

Jobs

See all jobs for Owkin here.

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Leads

Participating Firms

Angels